Renaud Descourt

3PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 18, 2025
Alectinib Efficacy Post-Brigatinib Against Advanced <i>ALK</i>+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study).

Renaud Descourt, Florian Guisier, Maurice Pérol

|Apr 12, 2022
Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study.

Renaud Descourt, Maurice Pérol, Gaëlle Rousseau-Bussac

|Jun 22, 2021
First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50.

Renaud Descourt, Christos Chouaid, Maurice Pérol

Pageof 1

Frequent Collaborators

3 joint publications

Christos Chouaid

2 joint publications

Maurice Pérol

2 joint publications

Florian Guisier

1 joint publications

Gaëlle Rousseau-Bussac